30 Sept 2026, 17:03
Director Interests—
1AIALGORAE PHARMACEUTICALS LIMITED
Announcement history available from 1 August 2025
Fromto
10 Sept 2026, 08:22
Meetings & Governance—
2 Sept 2026, 17:19
Securities Administration—
31 Aug 2026, 16:06
Company Administration—
31 Aug 2026, 16:02
Financial ResultsMS
31 July 2026, 09:14
Quarterly ReportsMS
21 July 2026, 17:19
Director Interests—
21 July 2026, 17:16
Director Interests—
21 July 2026, 17:14
Securities Administration—
15 July 2026, 08:59
Company Administration—
6 July 2026, 16:29
Securities Administration—
6 July 2026, 16:26
Securities Administration—
3 July 2026, 09:03
Company UpdateMS
2 July 2026, 09:47
Company UpdateMS
1 July 2026, 09:03
Company UpdateMS
30 June 2026, 16:19
Company Administration—
29 June 2026, 09:02
Company Update—
24 June 2026, 18:27
Other—
19 June 2026, 17:18
Securities Administration—
19 June 2026, 17:15
Securities Administration—
19 June 2026, 17:12
Securities Administration—
16 June 2026, 18:03
Securities Administration—
25 May 2026, 17:23
Securities Administration—
25 May 2026, 17:19
Securities Administration—
18 May 2026, 08:54
Company UpdateMS
6 May 2026, 08:54
Company UpdateMS
30 Apr 2026, 08:39
Quarterly ReportsMS
28 Apr 2026, 08:35
Company UpdateMS
21 Apr 2026, 08:37
Presentations—
7 Apr 2026, 17:23
Securities Administration—
7 Apr 2026, 17:17
Securities Administration—
7 Apr 2026, 17:13
Securities Administration—
7 Apr 2026, 17:13
Securities Administration—
2 Apr 2026, 17:14
Securities Administration—
2 Apr 2026, 17:08
Capital RaisingMS
2 Apr 2026, 09:38
Company UpdateMS
30 Mar 2026, 08:56
Company UpdateMS
27 Mar 2026, 18:15
Securities Administration—
27 Mar 2026, 18:10
Securities Administration—
20 Mar 2026, 09:00
Company Administration—
13 Mar 2026, 18:37
Securities Administration—
13 Mar 2026, 18:31
Securities Administration—
13 Mar 2026, 18:29
Securities Administration—
13 Mar 2026, 18:23
Securities Administration—
12 Mar 2026, 18:41
Director Interests—
12 Mar 2026, 18:34
Director Interests—
10 Mar 2026, 08:57
Company Administration—
5 Mar 2026, 18:25
Securities Administration—
5 Mar 2026, 18:20
Director Interests—
5 Mar 2026, 18:15
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 17:03 | Change of Director's Interest Notice - DH | Director Interests | — | 02009 | |
| 10 Sept 2026, 08:22 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 2 Sept 2026, 17:19 | Notification of cessation of securities - 1AI | Securities Administration | — | 06027 | |
| 31 Aug 2026, 16:06 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 16:02 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 31 July 2026, 09:14 | Quarterly Activities Report/Appendix 4C Cashflow Statement | Quarterly Reports | MS | 19004, 19009 | |
| 21 July 2026, 17:19 | Initial Director's Interest Notice - TV | Director Interests | — | 02008 | |
| 21 July 2026, 17:16 | Final Director's Interest Notice - BD | Director Interests | — | 02010 | |
| 21 July 2026, 17:14 | Notification of cessation of securities - 1AI | Securities Administration | — | 06027 | |
| 15 July 2026, 08:59 | Nasdaq Pharma Chairman Troy Valentine Joins Algorae Board | Company Administration | — | 12001 | |
| 6 July 2026, 16:29 | Cleansing Notice | Securities Administration | — | 06018 | |
| 6 July 2026, 16:26 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 3 July 2026, 09:03 | Peter Mac Testing Validates AlgoraeOS v2 | Company Update | MS | 11001 | |
| 2 July 2026, 09:47 | Updated - NSW Health Public Hospital Supply Contract | Company Update | MS | 11001, 12008 | |
| 1 July 2026, 09:03 | Algorae Awarded NSW Health Public Hospital Supply Contract | Company Update | MS | 11001 | |
| 30 June 2026, 16:19 | Company Secretary Appointment/Resignation | Company Administration | — | 12007 | |
| 29 June 2026, 09:02 | Algorae Named Launch Partner for Sovereign AI Initiative | Company Update | — | 11001 | |
| 24 June 2026, 18:27 | Change of Auditor | Other | — | 12018 | |
| 19 June 2026, 17:18 | Cleansing Notice | Securities Administration | — | 06018 | |
| 19 June 2026, 17:15 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 19 June 2026, 17:12 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 16 June 2026, 18:03 | Proposed issue of securities - 1AI | Securities Administration | — | 06013 | |
| 25 May 2026, 17:23 | Notification regarding unquoted securities - 1AI | Securities Administration | — | 06021 | |
| 25 May 2026, 17:19 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 18 May 2026, 08:54 | Algorae Expands AI Drug Combination Pipeline | Company Update | MS | 11001 | |
| 6 May 2026, 08:54 | 1AI Executes License & Supply Agreement with Torrent Pharma | Company Update | MS | 11001 | |
| 30 Apr 2026, 08:39 | Quarterly Activities Report /Appendix 4C Cash Flow Statement | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 08:35 | Algorae and Zydus Enter Exclusive Commercial Agreement | Company Update | MS | 11001 | |
| 21 Apr 2026, 08:37 | Investor Webinar | Presentations | — | 14014 | |
| 7 Apr 2026, 17:23 | Cleansing Notice | Securities Administration | — | 06018 | |
| 7 Apr 2026, 17:17 | Notification regarding unquoted securities - 1AI | Securities Administration | — | 06021 | |
| 7 Apr 2026, 17:13 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 7 Apr 2026, 17:13 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 2 Apr 2026, 17:14 | Proposed issue of securities - 1AI | Securities Administration | — | 06013 | |
| 2 Apr 2026, 17:08 | Algorae Pharmaceuticals Ltd Raises $3.9m | Capital Raising | MS | 06003, 06009 | |
| 2 Apr 2026, 09:38 | TGA Accepts Initial Registration Dossier for Evaluation | Company Update | MS | 11001 | |
| 30 Mar 2026, 08:56 | Peter Mac Partners with Algorae on AI Validation | Company Update | MS | 11001 | |
| 27 Mar 2026, 18:15 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 Mar 2026, 18:10 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 20 Mar 2026, 09:00 | Appointment of Mr Waleed Elsayed as Head of Sales | Company Administration | — | 12008 | |
| 13 Mar 2026, 18:37 | Cleansing Notice | Securities Administration | — | 06018 | |
| 13 Mar 2026, 18:31 | Application for quotation of securities - 1AI | Securities Administration | — | 06020 | |
| 13 Mar 2026, 18:29 | Notification regarding unquoted securities - 1AI | Securities Administration | — | 06021 | |
| 13 Mar 2026, 18:23 | Notification regarding unquoted securities - 1AI | Securities Administration | — | 06021 | |
| 12 Mar 2026, 18:41 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 12 Mar 2026, 18:34 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 10 Mar 2026, 08:57 | Algorae appoints Mr David Gulland to its Board of Directors | Company Administration | — | 12001, 12008 | |
| 5 Mar 2026, 18:25 | Notification regarding unquoted securities - 1AI | Securities Administration | — | 06021 | |
| 5 Mar 2026, 18:20 | Change of Director's Interest Notice - DH | Director Interests | — | 02009 | |
| 5 Mar 2026, 18:15 | Cleansing Notice | Securities Administration | — | 06018 |
1–50 of 97
1 / 2